Slower Clearance of Nevirapine Resistant Virus in Infants Failing Extended Nevirapine Prophylaxis for Prevention of Mother-to-Child HIV Transmission

Nevirapine resistance mutations arise commonly following single or extended-dose nevirapine (ED-NVP) prophylaxis to prevent mother-to-child transmission (PMTCT) of human immunodeficiency virus (HIV), but decay within 6–12 months of single-dose exposure. Use of ED-NVP prophylaxis in infants is expect...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Persaud, Deborah, Bedri, Abubaker, Ziemniak, Carrie, Moorthy, Anitha, Gudetta, Berhanu, Abashawl, Aida, Mengistu, Yohannes, Omer, Saad B., Isehak, Abdulhamid, Kumbi, Solomon, Adamu, Rahel, Lulseged, Sileshi, Ashworth, Roxann, Hassen, Elham, Ruff, Andrea
Natura: Artigo
Lingua:Inglês
Pubblicazione: Mary Ann Liebert, Inc. 2011
Soggetti:
Clinical Trials/Clinical Studies
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3149453/
https://ncbi.nlm.nih.gov/pubmed/21241214
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/aid.2010.0346
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi